We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+22.14%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.77B
AUM Growth
+$360M
Cap. Flow
+$138M
Cap. Flow %
7.81%
Top 10 Hldgs %
8.01%
Holding
874
New
148
Increased
244
Reduced
232
Closed
198

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$9.45M
2
SNAP icon
Snap
SNAP
+$8.6M
3
NU icon
Nu Holdings
NU
+$7.95M
4
SEDG icon
SolarEdge
SEDG
+$6.9M
5
STLA icon
Stellantis
STLA
+$5.73M

Top Sells

Rank Stock Value
1
SWKS icon
Skyworks Solutions
SWKS
+$8.29M
2
TRGP icon
Targa Resources
TRGP
+$7.01M
3
HUM icon
Humana
HUM
+$6.85M
4
AXSM icon
Axsome Therapeutics
AXSM
+$5.97M
5
ONON icon
On Holding
ONON
+$5.59M

Sector Composition

Rank Sector Weight
1 Technology 22.93%
2 Healthcare 15.99%
3 Consumer Discretionary 15.58%
4 Industrials 12.08%
5 Financials 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMC icon
551
FMC
FMC
$1.34B
$403K 0.02%
9,660
+858
+10% +$34.1K
BKE icon
552
Buckle
BKE
$2.25B
$399K 0.02%
+8,800
New +$348K
BFC icon
553
Bank First Corp
BFC
$1.69B
$397K 0.02%
3,375
OPRT icon
554
Oportun Financial
OPRT
$255M
$394K 0.02%
55,008
+24,379
+80% +$146K
BHVN icon
555
Biohaven
BHVN
$2.03B
$392K 0.02%
+27,800
New +$495K
ASTE icon
556
Astec Industries
ASTE
$1.16B
$386K 0.02%
9,263
VEL icon
557
Velocity Financial
VEL
$689M
$384K 0.02%
+20,702
New +$363K
NVCR icon
558
NovoCure
NVCR
$1.73B
$384K 0.02%
+21,558
New +$376K
SAGE
559
DELISTED
Sage Therapeutics
SAGE
$380K 0.02%
41,693
-74,835
-64% -$550K
ZIP icon
560
ZipRecruiter
ZIP
$321M
$380K 0.02%
75,816
-47,234
-38% -$258K
SWKS icon
561
Skyworks Solutions
SWKS
$9.37B
$379K 0.02%
5,090
-124,249
-96% -$8.29M
CCS icon
562
Century Communities
CCS
$1.91B
$379K 0.02%
+6,723
New +$377K
PI icon
563
Impinj
PI
$4.62B
$378K 0.02%
+3,400
New +$338K
SNBR
564
DELISTED
Sleep Number
SNBR
$371K 0.02%
+54,947
New +$419K
RIGL icon
565
Rigel Pharmaceuticals
RIGL
$681M
$371K 0.02%
19,809
-6
-0% -$114
UPS icon
566
United Parcel Service
UPS
$88.6B
$370K 0.02%
+3,667
New +$361K
BVS icon
567
Bioventus
BVS
$892M
$366K 0.02%
55,229
+42,072
+320% +$298K
GIC icon
568
Global Industrial
GIC
$1.37B
$365K 0.02%
13,526
-25,243
-65% -$634K
TEL icon
569
TE Connectivity
TEL
$59.6B
$364K 0.02%
2,156
+6
+0.3% +$911
CFLT
570
DELISTED
Confluent
CFLT
$363K 0.02%
+14,556
New +$328K
SKE
571
Skeena Resources
SKE
$3.3B
$358K 0.02%
22,487
-6
-0% -$76
NPK icon
572
National Presto Industries
NPK
$870M
$355K 0.02%
3,624
NBR icon
573
Nabors Industries
NBR
$1.27B
$355K 0.02%
12,669
-79,171
-86% -$2.36M
HY icon
574
Hyster-Yale Materials Handling
HY
$599M
$355K 0.02%
8,922
-10,420
-54% -$415K
NWN icon
575
Northwest Natural Holdings
NWN
$2.06B
$354K 0.02%
+8,916
New +$370K

Similar funds

PDT Partners's Q2 2025 Portfolio in Review

As of Q2 2025, PDT Partners held 874 positions worth $1.77B, up 26% from $1.41B the previous quarter. Its ten largest holdings account for 8% of the portfolio.

PDT Partners deployed $138M of net new capital in Q2 2025, opening 148 new positions and adding to 244 existing holdings. Its largest new stake was UBS Group: 305,378 shares worth $10.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Skyworks Solutions, an estimated $8.29M trimmed.

  • PDT Partners's largest Q2 2025 buy was UBS Group: 305,378 shares worth $10.3M.
  • PDT Partners added most to Snap in Q2 2025, an estimated $8.6M increase.
  • PDT Partners's biggest Q2 2025 reduction was Skyworks Solutions, cutting an estimated $8.29M.
  • PDT Partners fully exited Axsome Therapeutics in Q2 2025, selling an estimated $5.97M.
  • PDT Partners's ten largest holdings make up 8% of its $1.77B portfolio in Q2 2025.
  • PDT Partners opened 148 new positions and closed 198 in Q2 2025.
  • PDT Partners's portfolio value rose 26% quarter-over-quarter to $1.77B.

Based on PDT Partners's 13F filing for Q2 2025, filed 14 Aug 2025.